FindTrial
Sign In

A prospective controlled study of urinary exosomal glycoprotein detection in non-invasive diagnosis of bladder cancer

A prospective controlled study of urinary exosomal glycoprotein detection in non-invasive diagnosis of bladder cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070048
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

Gold Standard:pathological diagnosis
Index test:Detection of glycoprotein in urine

Sponsors

The First Affiliated Hospital of Navy Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients over 18 years old; (2) Patients preliminarily diagnosed with bladder cancer and planned for surgical treatment in our hospital; (3) Control group without bladder malignant tumor, including benign urothelial disease, agreed to collect morning urine for study; (4) Sign the informed consent of the enrolled clinical trial

Exclusion criteria

Exclusion criteria: (1) Unwilling to sign informed consent; (2) Patients unable to understand the study process, or unable/unwilling to answer questionnaires, provide medical records, examination reports and other relevant data; (3) Patients who did not comply with the study.

Design outcomes

Primary

MeasureTime frame
sensibility;Specificity;Concentration of markers in urinary exocrine fluid;—

Countries

China

Contacts

Public Contactzhangzhensheng

The First Affiliated Hospital of Navy Medical University

13761178177@163.com13761178177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026